BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• 

  Drug Development

  AstraZeneca CEO Says COVID-19 Vaccine Trial Pause is the Second Since July

  In July, the study was paused after another patient experienced neurological issues.

  September 10, 2020

   · 

  3 min read

   · 

  Alex Keown
• 

  Biotech Bay

  Satsuma Pharma’s Dry Powder Migraine Treatment Flops in Phase III Study

  Shares of Satsuma Pharmaceuticals plunged nearly 80% in premarket trading after the company revealed its late-stage migraine treatment failed to hit its co-primary endpoints.

  September 10, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Career Advice

  How to Deal with a Controlling Coworker

  Whether your controlling coworker wants to hold onto the data for their own use or refuses to compromise with you. Whatever, it is, it can lead to various problems.

  September 10, 2020

   · 

  3 min read

   · 

  Kymberlie Krieger
• 

  Business

  BioSpace Movers & Shakers, Sept. 11

  Biopharma and life sciences companies bolster their leadership teams and boards with these Movers & Shakers.

  September 10, 2020

   · 

  7 min read

   · 

  Alex Keown
• 

  FDA

  GSK’s Trelegy Ellipta Wins Approval as Treatment of Asthma

  GlaxoSmithKline’s Trelegy Ellipta won regulatory approval for the treatment of asthma in patients aged 18 years and older. Here’s what you need to learn.

  September 10, 2020

   · 

  2 min read

   · 

  Alex Keown
• 

  Policy

  Biopharma Update on the Novel Coronavirus: September 11

  Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for September 11, 2020.

  September 10, 2020

   · 

  2 min read

   · 

  BioSpace Editorial Staff
• 

  Genentech Presents New Data on Recently-Approved Enspryng

  Genetech provides new data on the recently approved drug Enspryng. Continue with the article to know more about the recent updates about this drug.

  September 10, 2020

   · 

  3 min read

   · 

  Mark Terry
• 

  Research Roundup: Why COVID-19 Is More Severe in the Elderly and Men and More

  Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.

  September 10, 2020

   · 

  5 min read

   · 

  Mark Terry
• 

  Drug Development

  Merck Makes Headway with V114 Vaccine Against Pneumococcal Disease

  Merck, known as MSD outside of the U.S. and Canada, announced on Wednesday that it has seen positive results regarding the safety, tolerability and immunogenicity of V114 in two Phase III studies.

  September 10, 2020

   · 

  3 min read

   · 

  Krystle Vermes
• 

  Business

  Anthos Therapeutics is Developing a Hemostasis-Sparing Anticoagulant to Reduce the Hazard of Bleeding

  Earlier this year, BioSpace tallied up the hottest U.S. biotech start-ups in their NextGen Bio Class of 2020 – Anthos Therapeutics was ranked #2.

  September 10, 2020

   · 

  8 min read

   · 

  Chelsea Weidman Burke